Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
Novo Nordisk starts phase 1 trial with oral insulin analogue
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
Sanofi-aventis enters into an Exclusive Global Licensing Agreement with The Rockefeller University
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](http://www.worldpharmanews.com/images/stories/logo/sanofi-avenits.gif)
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
- Details
- Category: Amgen
![Amgen Inc. Amgen Inc.](http://www.worldpharmanews.com/images/stories/logo/amgen.gif)
AstraZeneca and Targacept Form Global Collaboration and Licence Agreement
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Resource Guide About Key Issues Facing the Pharmaceutical Industry
- Details
- Category: Eli Lilly and Company
![Eli Lilly and Company Eli Lilly and Company](http://www.worldpharmanews.com/images/stories/logo/lilly.gif)
GSK's Arepanrix⢠H1N1 pandemic vaccine prequalified by the World Health Organization
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
More Pharma News ...
- Merck KGaA Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application
- Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment
- "Positive Charge" to Help Address Barriers and Provide Support to People Living with HIV/AIDS
- Bayer Starts Phase III Trial with Florbetaben
- Bayer starts pivotal Phase III trial with Florbetaben
- Novartis gains rights to two oral targeted investigational therapies
- Lundbeck initiates clinical phase II trials with Lu AE58054